These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4042092)

  • 21. Meta-analysis of randomized clinical trials in cancer.
    Buyse M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy for metastatic disease.
    Carter SK
    Symp Fundam Cancer Res; 1983; 36():397-410. PubMed ID: 6382516
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy and alternate randomized designs in cancer clinical trials.
    Zelen M
    Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase III trials in oncology: setting standards of care?
    Seeber S; Braun AH
    Nat Clin Pract Oncol; 2005 Sep; 2(9):426-7. PubMed ID: 16264993
    [No Abstract]   [Full Text] [Related]  

  • 26. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
    Emerson SS
    Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The phase III candidate: can we improve the science of selection?
    Bajorin D
    J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy protocol with taxol increase survival by 31 percent].
    Krankenpfl J; 2002; 40(7-9):226. PubMed ID: 12514866
    [No Abstract]   [Full Text] [Related]  

  • 29. The times they are a-changin' (Bob Dylan, 1964).
    Bradley DA; Redman BG
    Cancer; 2007 Dec; 110(11):2366-9. PubMed ID: 17941002
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials referral resource. Clinical trials using edatrexate.
    Cheson BD; Sorenson JM; Phillips PH
    Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
    [No Abstract]   [Full Text] [Related]  

  • 31. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic synergism.
    Stablein DM
    Biometrics; 1985 Dec; 41(4):1076-7. PubMed ID: 3913466
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of chemotherapy of soft tissue sarcoma in adults].
    Santoro A; Viviani S
    Radiol Med; 1984 Nov; 70(11):893-5. PubMed ID: 6399763
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemotherapy for cancer patients, ally or blind alley?
    Sleijfer DT; Mulder NH
    Neth J Med; 1985; 28(9):335-7. PubMed ID: 4047266
    [No Abstract]   [Full Text] [Related]  

  • 35. First-line treatment options for patients with metastatic colorectal cancer.
    Schilsky RL
    Nat Clin Pract Oncol; 2004 Dec; 1(2):70-1. PubMed ID: 16264820
    [No Abstract]   [Full Text] [Related]  

  • 36. Some considerations on the role of chemotherapy in individualization of cancer therapy.
    Tagnon HJ
    Strahlentherapie; 1984 Nov; 160(11):681-3. PubMed ID: 6506107
    [No Abstract]   [Full Text] [Related]  

  • 37. Concepts for the treatment of tumor metastasis.
    Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR
    Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolving therapy and management of metastatic colon cancer.
    Goldberg RM
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):159-60. PubMed ID: 16224396
    [No Abstract]   [Full Text] [Related]  

  • 39. Paclitaxel in the treatment of esophageal cancer.
    Weiner LM
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.